Liposomes in topical ophthalmic drug delivery: an update

References

• Abdelbary G. (2011). Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 16:44–56
   PubMed Web of Science ®Google Scholar
• Abdel-Rhaman MS, Soliman W, Habib F, Fathalla D. (2012). A new long-acting liposomal topical antifungal formula: human clinical study. Cornea 31:126–9
   PubMed Web of Science ®Google Scholar
• Abdul Nasir NA, Agarwal R, Tripathy M, et al. (2013). Tocotrienol delays onset and progression of galactose-induced cataract in rat. Abstracts of the 12th Meeting of the Asia Pacific Federation of Pharmacologists. Shanghai, China, July 9–13, 2013. Acta Pharmacol Sin 34:147
   Web of Science ®Google Scholar
• Afouna MI, Khattab IS, Reddy IK. (2005). Preparation and characterization of demeclocycline liposomal formulations and assessment of their intraocular pressure-lowering effects. Cutan Ocul Toxicol 24:111–24
   PubMed Web of Science ®Google Scholar
• Ahmed I, Gokhale RD, Shah MV, Patton TF. (1987). Physicochemical determinants of drug diffusion across the conjunctiva, sclera and cornea. J Pharm Sci 76:583–6
   PubMed Web of Science ®Google Scholar
• Alghadyan AA, Peyman GA, Khoobehi B, et al. (1988). Liposome-bound cyclosporine: aqueous and vitreous level after subconjunctival injection. Int Ophthalmol 12:101–4
   PubMed Web of Science ®Google Scholar
• Allen TM, Mc Allister L, Mausolf S, Gyorffy E. (1981). Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines. Biochimica et Biophysica Acta 643:346–62
   PubMed Web of Science ®Google Scholar
• Anderson JA, Davis WL, Wei CP. (1980). Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine. Invest Ophthalmol Vis Sci 19:817–23
   PubMed Web of Science ®Google Scholar
• Assil KK, Frucht-Perry J, Ziegler E, et al. (1991). Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis. Invest Ophthalmol Vis Sci 32:3216–20
   PubMed Web of Science ®Google Scholar
• Bangham AD. (1972). Lipid bilayers and biomembranes. Ann Rev Biochem 41:753–76
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
   PubMed Web of Science ®Google Scholar
• Barber RF, Shek PN. (1986). Liposomes and tear fluid. I. Release of vesicle-entrapped carboxyfluorescein. Biochim Biophys Acta 879:157–63
   PubMed Web of Science ®Google Scholar
• Barber RF, Shek PN. (1990). Tear induced release of liposome entrapped agents. Int J Pharm 60:219–27
   Web of Science ®Google Scholar
• Barza M. (1980). Treatment of bacterial infections of the eye. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. Vol. 1. New York: McGraw-Hill Book Company, 158–94
   Google Scholar
• Barza M, Baum J, Szoka Jr F. (1984). Pharmacokinetics of subconjunctival liposome-encapsulated gentamicin in normal rabbit eyes. Invest Ophthalmol Vis Sci 25:486–90
   PubMed Web of Science ®Google Scholar
• Barza M, Stuart M, Szoka Jr F. (1987). Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Invest Ophthalmol Vis Sci 28:893–900
   PubMed Web of Science ®Google Scholar
• Baum J, Barza M. (1983). Topical vs. subconjunctival treatment of bacterial corneal ulcers. Ophthalmology 90:162–8
   PubMed Web of Science ®Google Scholar
• Benita S, Plenecassagne JD, Cave G, et al. (1984). Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye. J Microencapsul 1:203–16
   PubMedGoogle Scholar
• Blume G, Cevc G. (1993). Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157–68
   PubMed Web of Science ®Google Scholar
• Blume G, Cevc G, Crommelin MD, et al. (1993). Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta 1149:180–4
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E, Gulik A, et al. (1998). Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm Res 15:1364–9
   PubMed Web of Science ®Google Scholar
• Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF. (2009). Colloidal soft matter as drug delivery system. J Pharmaceut Sci 98:1–42
   PubMed Web of Science ®Google Scholar
• Budai L, Hajdú M., Budai M, et al. (2007). Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int J Pharm 343:34–40
   PubMed Web of Science ®Google Scholar
• Chetoni P, Rossi S, Burgalassi S, et al. (2004). Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits. J Ocul Pharmacol Ther 20:169–77
   PubMed Web of Science ®Google Scholar
• Chien D-S, Sasaki H, Bundgaard H, et al. (1991). Role of enzymatic lability in the cornea and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm Res 8:728–33
   PubMed Web of Science ®Google Scholar
• Craig JP, Purslow C, Murphy PJ, Wolffsohn JS. (2010). Effect of a liposomal spray on the pre-ocular tear film. Cont Lens Anterior Eye 33:83–7
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. (2013). Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine 8:1921–33
   PubMed Web of Science ®Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. (1992). Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. Pharm Res 9:1137–44
   PubMed Web of Science ®Google Scholar
• Dharma SK, Fishman PH, Peyman GA. (1986). A preliminary study of corneal penetration of 125l-labelled idoxuridine liposome. Acta Ophthalmol (Copenh.) 64:298–301
   Google Scholar
• Durrani AM, Davies NM, Thomas M, Kellaway IW. (1992). Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. Int J Pharm 88:409–15
   Web of Science ®Google Scholar
• Duzgunes N, Nir S. (1999). Mechanisms and kinetics of liposome–cell interactions. Adv Drug Deliv Rev 40:3–18
   PubMed Web of Science ®Google Scholar
• El-Shazly AH, El-Shazly LH, El-Gohary AA. (2009). The potential effect of liposome encapsulated tetracycline topical application for the management of experimental dry eye model in albino rabbits. Med J Cairo Univ 77:149–57
   Google Scholar
• El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm 158:121–7
   Web of Science ®Google Scholar
• Farooq AV, Shukla D. (2012). Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57:448–62
   PubMed Web of Science ®Google Scholar
• Federici TJ. (2011). The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease. Pharmacol Res 64:614–23
   PubMed Web of Science ®Google Scholar
• Felt O, Baeyens V, Zignani M, et al. (1999b). Mucosal drug delivery. In: Mathiowitz E, ed. The encyclopedia of controlled drug delivery. New York: Wiley, 605–26
   Google Scholar
• Felt O, Furrer P, Mayer JM, et al. (1999a). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm 180:185–93
   PubMed Web of Science ®Google Scholar
• Fielding RM. (1991). Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clin Pharmacokinet 21:155–64
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, Hadgraft J, Wilson CG. (1987). A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit. J Pharm Pharmacol 39:487–90
   PubMed Web of Science ®Google Scholar
• Fresta M, Panico A, Bucolo C, et al. (1999). Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir. J Pharm Pharmacol 51:565–76
   PubMed Web of Science ®Google Scholar
• Frucht-Perry J, Assil KK, Ziegler E, et al. (1992). Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis. Cornea 11:393–7
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Miyai H, Hironaka K, et al. (2012). Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm 436:564–7
   PubMed Web of Science ®Google Scholar
• Gabizon A, Horowitz AT, Goren D, et al. (1999). Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10:289–98
   PubMed Web of Science ®Google Scholar
• Geroski DH, Edelhauser HF. (2001). Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev 52:37–48
   PubMed Web of Science ®Google Scholar
• Ghosh S, Jhanji V, Lamoureux E, et al. (2008). Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am J Ophthalmol 145:198–202
   PubMed Web of Science ®Google Scholar
• Goldbach P, Herve B, Pascal W, Andre S. (1995). Sterile filtration of liposomes: retention of encapsulated carboxyfluorescein. Int J Pharm 117:225–30
   Web of Science ®Google Scholar
• Gregoriadis G, Wills EJ, Swain C, Tavill AS. (1974). Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1:1313–6
   PubMed Web of Science ®Google Scholar
• Gupta SK, Dhingra N, Velpandian T, Jaiswal J. (2000). Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes. Acta Ophthalmol Scand 78:448–50
   PubMedGoogle Scholar
• Gurny R, Ibrahim H, Aebi A, et al. (1987). Design and evaluation of controlled release systems for the eye. J Control Release 6:367–73
   Google Scholar
• Habib FS, Fouad EA, Abdel-Rhaman MS, Fathalla D. (2010). Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol 88:901–4
   PubMed Web of Science ®Google Scholar
• Hämäläinen KM, Kontturi K, Murtomäki L, et al. (1997a). Estimation of pore size and porosity of biomembranes from permeability measurements of polyethylene glycols using an effusion-like approach. J Control Release 49:97–104
   Web of Science ®Google Scholar
• Hämäläinen KM, Kananen K, Auriola S, et al. (1997b). Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 38:627–34
   PubMed Web of Science ®Google Scholar
• Harris D, Liaw JH, Robinson JR. (1992). Routes of delivery: case studies: ocular delivery of peptide and protein drugs. Adv Drug Deliv Rev 8:331–9
   Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharmscitech 8:E1–12
   PubMed Web of Science ®Google Scholar
• Hironaka K, Inokuchi Y, Fujisawa T, et al. (2011). Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage. Eur J Pharm Biopharm 79:119–25
   PubMed Web of Science ®Google Scholar
• Hosny KM. (2010). Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech 11:241–6
   PubMed Web of Science ®Google Scholar
• Huang AJ, Tseng SC, Kenyon KR. (1989). Paracellular permeability of corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci 30:684–9
   PubMed Web of Science ®Google Scholar
• Huang HS, Schoenwald RD, Lach JL. (1983). Corneal penetration behavior of beta-blocking agents: II. Assessment of barrier contributions. J Pharm Sci 72:1272–9
   PubMed Web of Science ®Google Scholar
• Mokhtar Ibrahim M, Tawfique SAH, Mahdy MM. (2014). Liposomal diltiazem HCl as ocular drug delivery system for glaucoma. Drug Dev Ind Pharm 40:765–73
   PubMed Web of Science ®Google Scholar
• Iezhitsa I, Agarwal R, Awaludin NA, et al. (2013). Evaluation of the anticataract effects of magnesium taurate in vitro. Abstracts of the 12th Meeting of the Asia Pacific Federation of Pharmacologists. Shanghai, China, July 9–13, 2013. Acta Pharmacol Sin 34:24
   PubMed Web of Science ®Google Scholar
• Inokuchi Y, Hironaka K, Fujisawa T, et al. (2010). Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eye drop administration. Invest Ophthalmol Vis Sci 51:3162–70
   PubMed Web of Science ®Google Scholar
• Ito Y, Cai H, Koizumi Y, et al. (2000). Effects of lipid composition on the transcorneal penetration of liposomes containing disulfiram, a potential anti-cataract agent, in the rabbit. Biol Pharm Bull 23:327–33
   PubMed Web of Science ®Google Scholar
• Jain RL, Shastri JP. (2011). Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Investig 1:35–41
   PubMedGoogle Scholar
• Katragadda S, Gunda S, Hariharan S, Mitra AK. (2008). Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int J Pharm 359:15–24
   PubMed Web of Science ®Google Scholar
• Kaufman HE, Steinemann TL, Lehman E, et al. (1994). Collagen-based drug delivery and artificial tears. J Ocul Pharmacol 10:17–27
   PubMedGoogle Scholar
• Kitagawa K, Fukuda M, Sasaki K. (1989). Intraocular penetration of topically administered acyclovir. Lens Eye Toxic Res 6:365–73
   PubMedGoogle Scholar
• Klibanov AL, Maruyama K, Torchilin VP, Huang L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–7
   PubMed Web of Science ®Google Scholar
• Knoll G, Burger KNJ, Bron R, et al. (1988). Fusion of liposomes with the plasma membrane of epithelial cells: fate of incorporated lipids as followed by freeze fracture and autoradiography of plastic sections. J Cell Biol 107:2511–21
   PubMed Web of Science ®Google Scholar
• Kompella UB, Katragadda AK, Aukunuru JV, Betageri GV. (1998). Effect of liposomal charge on stavudine transport across rabbit cornea and conjunctiva. Pharm Pharmacol Commun 4:339–43
   Google Scholar
• Kuesters GM, Campbell RB. (2010). Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential. Nanomedicine (Lond.) 5:181–92
   PubMed Web of Science ®Google Scholar
• Laufer SD, Restle T. (2008). Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems. Curr Pharm Des 14:3637–55
   PubMed Web of Science ®Google Scholar
• Law SL, Huang KJ, Chiang CH. (2000). Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control Release 63:135–40
   PubMed Web of Science ®Google Scholar
• Lee VH, Carson LW. (1986). Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics. J Ocul Pharmacol 2:353–64
   PubMedGoogle Scholar
• Lee VH, Urrea PT, Smith RE, Schanzlin DJ. (1985). Ocular drug bioavailability from topically applied liposomes. Surv Ophthalmol 29:335–48
   PubMed Web of Science ®Google Scholar
• Lee VHL, Carson LW, Kashi SD, Stratford RE. (1986). Metabolic and permeation barriers to the ocular absorption of topically applied encephalins in albino rabbits. J Ocul Pharmacol 2:345–52
   PubMedGoogle Scholar
• Lee VH, Robinson JR. (1986). Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol Ther 2:67–108
   Google Scholar
• Lee WC, Tsai TH. (2010). Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int J Pharm 395:78–83
   PubMed Web of Science ®Google Scholar
• Lehtonen JY, Kinnunen PK. (1995). Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes. Biophys J 68:525–35
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Wang M, et al. (2009). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379:131–8
   PubMed Web of Science ®Google Scholar
• Li Y, Cheng Q, Jiang Q, et al. (2013). Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA. J Control Release. Available from: ISSN 0168-3659, http://dx.doi.org/10.1016/j.jconrel.2013.12.007 [last accessed 21 Dec 2013]
   Google Scholar
• Liaw J, Robinson JR. (1992). The effect of poly ethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers. Int J Pharm 88:125–40
   Web of Science ®Google Scholar
• Lin HH, Ko SM, Hsu LR, Tsai YH. (1996). The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig’s eye. J Pharm Pharmacol 48:801–5
   PubMed Web of Science ®Google Scholar
• Lindén C, Alm A. (1990). The effect of reduced tear drainage on corneal and aqueous concentrations of topically applied fluorescein. Acta Ophthalmol (Copenh.) 68:633–8
   Google Scholar
• Lipowsky R. (1995). Generic interactions of flexible membranes. In: Lipowsky R, Sackmann E, eds. Handbook of biological physics. Chapter 11. Vol 1. The Netherlands: B.V. Elsevier Science, 521–602
   Google Scholar
• Loomis K, Smith B, Feng Y, et al. (2010). Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv. Exp Mol Pathol 88:238–49
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61
   PubMed Web of Science ®Google Scholar
• Mahmoud SS, Gehman JD, Azzopardi K, et al. (2008). Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications. J Pharm Sci 97:2691–701
   PubMed Web of Science ®Google Scholar
• Mannermaa E, Vellonen KS, Urtti A. (2006). Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63
   PubMed Web of Science ®Google Scholar
• Massey JY, Hanna C, Goodart R, Wallace T. (1976). Effect of drug vehicle on human ocular retention of topically applied tetracycline. Am J Ophthalmol 81:151–6
   PubMed Web of Science ®Google Scholar
• Masuda I, Matsuo T, Yasuda T, Matsuo N. (1996). Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 37:1914–20
   PubMed Web of Science ®Google Scholar
• Matsuo T, Masuda I, Yasuda T, Matsuo N. (1996). Gene transfer to the retina of rat by liposome eye drops. Biochem Biophys Res Commun 219:947–50
   PubMed Web of Science ®Google Scholar
• Maurice DM, Mishima S. (1984). Ocular pharmacokinetics. In: Sears MC, ed. Handbook of experimental pharmacology, pharmacology of the eye. Vol. 69. Berlin, Heidelberg: Springer-Verlag, 16–119
   Google Scholar
• Mehanna MM, Elmaradny HA, Samaha MW. (2010). Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment. Drug Dev Ind Pharm 36:108–18
   PubMed Web of Science ®Google Scholar
• Milani JK, Pleyer U, Dukes A, et al. (1993). Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 100:890–6
   PubMed Web of Science ®Google Scholar
• Mindel JS, Cohen G, Barker LA, Lewis DE. (1984). Enzymatic and nonenzymatic hydrolysis of d, l-dipivefrin. Arch Ophthalmol 102:457–60
   PubMed Web of Science ®Google Scholar
• Monem AS, Ali FM, Ismail MW. (2000). Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharmaceutics 198:29–38
   PubMed Web of Science ®Google Scholar
• Mosallaei N, Banaee T, Farzadnia M, et al. (2012). Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration. Curr Eye Res 37:453–6
   PubMed Web of Science ®Google Scholar
• Nag O, Awasthi V. (2013). Surface engineering of liposomes for stealth behavior. Pharmaceutics 5:542–69
   PubMedGoogle Scholar
• Natarajan JV, Ang M, Darwitan A, et al. (2012). Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomedicine 7:123–31
   PubMed Web of Science ®Google Scholar
• Norley SG, Sendele D, Huang L, Rouse BT. (1987). Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes. Invest Ophthalmol Vis Sci 28:591–5
   PubMed Web of Science ®Google Scholar
• Norn MS. (1965). Tear secretion in normal eyes. Estimated by a new method: the lacrimal streak dilution test. Acta Ophthalmologica 43:567–73
   PubMed Web of Science ®Google Scholar
• Pal Kaur I, Kanwar M. (2002). Ocular preparations: the formulation approach. Drug Dev Ind Pharm 28:473–93
   PubMed Web of Science ®Google Scholar
• Park DJJ, Karesh JW. (2006). Topographic anatomy of eye. In: Tasman W, Jaeger EA, eds. Duane’s foundations of clinical ophthalmology on CD Rom. Vol. 1. Chapter 1. Philadelphia: Lippincott Williams & Wilkins
   Google Scholar
• Patton TF, Robinson JR. (1976). Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J Pharm Sci 65:1295–301
   PubMed Web of Science ®Google Scholar
• Perche F, Torchilin VP. (2013). Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J Drug Deliv 2013 (2013), Article ID 705265, 32 pages. doi:10.1155/2013/705265
   Google Scholar
• Peters E, Colby K. (2006). The tear film. In: Tasman W, Jaeger EA, eds. Duane’s foundations of clinical ophthalmology on CD Rom. Vol. 2. Chapter 3. Philadelphia: Lippincott Williams & Wilkins
   Google Scholar
• Pleyer U, Elkins B, Rückert D, et al. (1994). Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 13:177–81
   PubMed Web of Science ®Google Scholar
• Pleyer U, Grammer J, Pleyer JH, et al. (1995). Amphotericin B–bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B. Ophthalmologe 92:469–75
   PubMedGoogle Scholar
• Pleyer U, Lutz S, Jusko WJ, et al. (1993). Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol Vis Sci 34:2737–42
   PubMed Web of Science ®Google Scholar
• Prabhu P, Nitish KR, Koland M, et al. (2010). Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system. J Young Pharm 2:356–61
   PubMedGoogle Scholar
• Prausnitz MR, Noonan JS. (1998). Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479–88
   PubMed Web of Science ®Google Scholar
• Pult H, Gill F, Riede-Pult BH. (2012). Effect of three different liposomal eye sprays on ocular comfort and tear film. Cont Lens Anterior Eye 35:203–7
   PubMed Web of Science ®Google Scholar
• Rathod S, Deshpande SG. (2010). Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian J Pharma Sci 72:155–60
   PubMed Web of Science ®Google Scholar
• Rosin A. (1991). Pilocarpine. A miotic of choice in the treatment of glaucoma has passed 110 years of use. Oftalmologia (Romania) 35:53–5
   PubMedGoogle Scholar
• Saad SD, Zakaria FK, Azizan IL, et al. (2013). Calcium and magnesium level in cataractous lenses of galactosemic rats topically treated with liposomal formulation of magnesium taurate. Abstracts of the 12th Meeting of the Asia Pacific Federation of Pharmacologists. Shanghai, China, July 9–13, 2013. Acta Pharmacol Sin 34:147
   Web of Science ®Google Scholar
• Salminen L. (1977). Penetration of ocular compartments by tetracyclines. Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 204:189–99
   PubMedGoogle Scholar
• Sangare L, Morisset R, Ravaoarinoro M. (1999). In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline. J Med Microbiol 48:689–93
   PubMed Web of Science ®Google Scholar
• Sasaki H, Igarashi Y, Nagano T, et al. (1995). Penetration of β-blockers through ocular membranes in albino rabbits. J Pharm Pharmacol 47:17–21
   Web of Science ®Google Scholar
• Schaeffer HE, Breitfeller JM, Krohn DL. (1982). Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux. Invest. Ophthalmol Vis Sci 23:530–3
   PubMed Web of Science ®Google Scholar
• Schaeffer HE, Krohn DL. (1982). Liposomes in topical drug delivery. Invest Ophthalmol Vis Sci 22:220–7
   PubMed Web of Science ®Google Scholar
• Schwendener RA. (2007). Liposomes in biology and medicine. Adv Exp Med Biol 620:117–28
   PubMed Web of Science ®Google Scholar
• Senior J, Gregoriadis G. (1982). Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol com-ponents. Life Sci 30:2123–36
   PubMed Web of Science ®Google Scholar
• Sessa G, Weissmann G. (1968). Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res 9:310–8
   PubMed Web of Science ®Google Scholar
• Shafaa MW, El Shazly LH, El Shazly AH, et al. (2011). Efficacy of topically applied liposome-bound tetracycline in the treatment of dry eye model. Vet Ophthalmol 14:18–25
   PubMed Web of Science ®Google Scholar
• Shen Y, Tu J. (2007). Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J 9:E371–7
   PubMed Web of Science ®Google Scholar
• Shimazaki H, Hironaka K, Fujisawa T, et al. (2011). Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice. Invest Ophthalmol Vis Sci 52:7289–97
   PubMed Web of Science ®Google Scholar
• Sieg JW, Robinson JR. (1976). Mechanistic studies on transcorneal permeation of pilocarpine. J Pharm Sci 65:1816–22
   PubMed Web of Science ®Google Scholar
• Simmons ST, Sherwood MB, Nichols DA, et al. (1988). Pharmacokinetics of a 5-fluorouracil liposomal delivery system. Br J Ophthalmol 72:688–91
   PubMed Web of Science ®Google Scholar
• Stephen GN, Deborah S, Leaf H, Barry TR. (1987). Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes. Invest Ophthalmol Vis Sci 28:591–5
   PubMed Web of Science ®Google Scholar
• Sun KX, Wang AP, Huang LJ, et al. (2006). Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics. Yao Xue Xue Bao 41:1094–8
   PubMedGoogle Scholar
• Szebeni J, Baranyi L, Savay S, et al. (2002). Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 12:165–72
   PubMed Web of Science ®Google Scholar
• Taha EL, El-Anazi MH, El-Bagory IM, Bayomi MA. (2014). Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharmaceutical Journal, 22:231–9 http://dx.doi.org/10.1016/j.jsps.2013.07.003
   Google Scholar
• Tan PH, Manunta M, Ardjomand N, et al. (2003). Antibody targeted gene transfer to endothelium. J Gene Med 5:311–23
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Yamamoto Y, Itakura K, et al. (1988). Assessment of ocular irritability of liposome preparations. J Pharmacobiodyn 11:607–11
   PubMedGoogle Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Disc 4:145–60
   PubMed Web of Science ®Google Scholar
• Toropainen E, Ranta VP, Vellonen KS, et al. (2003). Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Sci 20:99–106
   PubMed Web of Science ®Google Scholar
• Ueda H, Horibe Y, Kim KJ, Lee VH. (2000). Functional characterization of organic cation drug transport in the pigmented rabbit conjunctiva. Invest Ophthalmol Vis Sci 41:870–6
   PubMed Web of Science ®Google Scholar
• Urtti A, Pippin JD, Rork GS, et al. (1990). Controlled drug delivery devices for experimental ocular studies with timolol. 2. Ocular and systemic absorption in rabbits. Int J Pharm 61:241–9
   Web of Science ®Google Scholar
• Urtti A, Salminen L. (1993). Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 37:435–56
   PubMed Web of Science ®Google Scholar
• Urtti A, Salminen L, Miinalaincn O. (1985). Systemic absorption of ocular pilocarpine is modified by polymer matrices. Int J Pharm 23:147–61
   Web of Science ®Google Scholar
• Urtti A, Rouhiainen H, Kaila T, Saano V. (1994). Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans. Pharm Res 11:1278–82
   PubMed Web of Science ®Google Scholar
• Wang W, Sasaki H, Chien DS, Lee VH. (1991). Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr Eye Res 10:571–9
   PubMed Web of Science ®Google Scholar
• Weiner N, Martin F, Riox M. (1989). Liposomes as drug delivery system. Drug Dev Ind Pharm 15:1523–54
   Web of Science ®Google Scholar
• Weissmann G, Sessa G, Weissmann S. (1985). Effect of steroids and ‘Triton X-100’ on glucose-filled phospholipid/cholesterol structures. Nature 208:649–51
   Web of Science ®Google Scholar
• Whitcup SM, Pleyer U, Lai JC, et al. (1998). Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. Ocul Immunol Inflamm 6:51–6
   PubMed Web of Science ®Google Scholar
• Wojewodzka J, Pazdzior G, Langne M. (2005). A method to evaluate the effect of liposome lipid composition on its interaction with the erythrocyte plasma membrane. Chem Phys Lipids 135:181–7
   PubMed Web of Science ®Google Scholar
• Wutzler P, Sauerbrei A, Clocking R, et al. (2000). Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex. Ophthalmic Res 32:118–25
   PubMed Web of Science ®Google Scholar
• Yamashita T, Sonoda S, Suzuki R, et al. (2007). A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res 85:741–8
   PubMed Web of Science ®Google Scholar
• Yerushalmi N, Margalit R. (1994). Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers. Biochim Biophys Acta 1189:13–20
   PubMed Web of Science ®Google Scholar
• Yoshihara E, Nakae T. (1986). Cytolytic activity of liposomes containing stearylamine. Biochim Biophys Acta 854:530–46
   Web of Science ®Google Scholar
• Yoshizumi MO, Cohen D, Verbukh I, et al. (1991). Experimental transscleral iontophoresis of ciprofloxacin. J Ocul Pharmacol 7:163–7
   PubMedGoogle Scholar
• Zakaria FK, Saad SD, Azizan IL, et al. (2013). Effects of magnesium taurate in liposomal formulation on the onset and progression of cataract in galactose-fed rats. Abstracts of the 12th Meeting of the Asia Pacific Federation of Pharmacologists. Shanghai, China, July 9–13, 2013. Acta Pharmacol Sin 34:159
   Web of Science ®Google Scholar
• Zeng S, Hu C, Wei H, et al. (1993). Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model. Ophthalmology 100:1640–4
   Google Scholar
• Zhang J, Wang S. (2009). Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. Int J Pharm 372:66–75
   PubMed Web of Science ®Google Scholar